Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Please note that all translations are automatically generated. Click here for the English version.
7.1K Views
•
08:59 min
•
December 11th, 2017
DOI :
December 11th, 2017
•Rozdziały w tym wideo
0:05
Title
1:39
Generation of Targeted Therapy Resistant Subclones
4:03
Restoring Target-therapy Inhibitor Sensitivity by Candidate R-gene Knock-down
6:31
Results: Drug Resistant Subclone Generation and Sensitivity Restoration
8:01
Conclusion
Powiązane Filmy
09:58
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
13.6K Views
09:38
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
8.7K Views
07:42
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
7.9K Views
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
8.2K Views
12:28
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
7.3K Views
09:38
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
7.9K Views
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
3.1K Views
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
8.3K Views
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
10.5K Views
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
14.8K Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone